Jinhai Medical Technology (HKG:2225) entered into a cooperation memorandum with Digital Health China Technologies to explore potential cooperation in business operations and equity investments, according to a Monday Hong Kong bourse filing.
The parties plan to explore merger and acquisition opportunities and equity investments, leveraging their respective resources, technologies, marketing and management capabilities.
Jinhai has exclusive negotiation rights with Digital Health on the proposed matters through March 31, 2027.
Any cooperation remains subject to further negotiations, due diligence, internal approvals, and formal agreements.
Comments